Compass Therapeutics, Inc.(CMPX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CMPX Compass Therapeutics, Inc.

Market Closed 08-28 16:00:00 EDT

2.40

-0.12

-4.76%

盘后2.42

+0.02+0.83%

19:49 EDT

High2.51	Low2.40	Vol2.57M
Open2.51	D1 Closing2.52	Amplitude4.37%
Mkt Cap432.21M	Tradable Cap316.80M	Total Shares180.09M
T/O6.30M	T/O Rate1.95%	Tradable Shares132.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CMPX","market":"US","secType":"STK","nameCN":"Compass Therapeutics, Inc.","latestPrice":2.4,"timestamp":1787947200000,"preClose":2.52,"halted":0,"volume":2567637,"hourTrading":{"tag":"盘后","latestPrice":2.42,"preClose":2.4,"latestTime":"19:49 EDT","volume":17761,"amount":42657.9039,"timestamp":1787960974940,"change":0.02,"changeRate":0.008333,"amplitude":0.016667},"delay":0,"changeRate":-0.04761904761904766,"floatShares":132000000,"shares":180087915,"eps":-0.403923,"marketStatus":"Market Closed","change":-0.12,"latestTime":"08-28 16:00:00 EDT","open":2.51,"high":2.51,"low":2.4,"amount":6304493.2118886,"amplitude":0.043651,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.403923,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"listingDate":1605243600000,"exchange":"NASDAQ","adjPreClose":2.52,"preHourTrading":{"tag":"盘前","latestPrice":2.51,"preClose":2.52,"latestTime":"09:29 EDT","volume":3194,"amount":8044.4904858,"timestamp":1787923770112,"change":-0.01,"changeRate":-0.003968,"amplitude":0.014286},"postHourTrading":{"tag":"盘后","latestPrice":2.42,"preClose":2.4,"latestTime":"19:49 EDT","volume":17761,"amount":42657.9039,"timestamp":1787960974940,"change":0.02,"changeRate":0.008333,"amplitude":0.016667},"volumeRatio":1.477539,"impliedVol":1.2379,"impliedVolPercentile":0.4582},"requestUrl":"/m/hq/s/CMPX","defaultTab":"news","newsList":[{"id":"2658317659","title":"Compass Therapeutics Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658317659","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658317659?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:31","pubTimestamp":1786368708,"startTime":"0","endTime":"0","summary":"Compass Therapeutics Inc. reports results for the quarter ended June 30 - Earnings SummaryCompass Therapeutics Inc.CMPX.OQreported a quarterly adjusted loss of 13 cents per share for the quarter ended","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N44715H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657618785","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657618785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657618785?lang=en_us&edition=fundamental","pubTime":"2026-08-07 15:30","pubTimestamp":1786087809,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Compass Therapeutics (CMPX) and ICU Medical (ICUI) w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-286?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-286?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0240878834.USD","LU0205194284.USD","BK4139","ICUI","SG9999015978.USD","LU0106261612.USD","SG9999015952.SGD","LU0240877869.USD","CMPX","LU0205193047.USD","SG9999015986.USD","SG9999015945.SGD","BK4198","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657364660","title":"Analysts Offer Insights on Healthcare Companies: Compass Therapeutics (CMPX) and Halozyme (HALO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657364660","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657364660?lang=en_us&edition=fundamental","pubTime":"2026-08-07 09:40","pubTimestamp":1786066808,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Compass Therapeutics (CMPX) and Halozyme (HALO) with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-compass-therapeutics-cmpx-and-halozyme-halo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-compass-therapeutics-cmpx-and-halozyme-halo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XLV","XBI","BK4585","HALO","LU0053671581.USD","CMPX","LU0029874061.USD","BK4581","BK4137","LU0128526141.USD","BK4139","HCSG","FFOX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657668017","title":"Relay Therapeutics Q2 Revenue Misses Estimates on Higher R&D Expenses; Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2657668017","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657668017?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:40","pubTimestamp":1786048849,"startTime":"0","endTime":"0","summary":"Relay Therapeutics Q2 revenue misses estimates on higher R&D expenses; net loss widensOverviewUS precision medicine developer's Q2 revenue declined and missed analyst expectationsNet loss for Q2 widen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431FA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","CMPX","BK4139","RLAY","BK4539","GLUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657463906","title":"Compass Therapeutics Q2 2026 earnings: Pipeline spending widens the net loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2657463906","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657463906?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:23","pubTimestamp":1786018982,"startTime":"0","endTime":"0","summary":"Compass Therapeutics’ Q2 2026 earnings showed a net loss of $25.2 million, compared with $19.9 million a year earlier, while basic and diluted loss per share narrowed to $0.13 from $0.14 as the weighted-average share count increased. R&D expense rose 19% to $19.6 million, largely due to tovecimig, and G&A expense increased 59% to $7.4 million. The company ended June with $180 million in cash and marketable securities, expects runway into 2028, and is awaiting Q3 FDA feedback before a potential tovecimig BLA filing later in 2026.","market":"nz","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock1.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock1.jpg"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/earnings/262083760-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FEBU","DECU","JOYT","RGLO","PMDE","GXDW","CMPX","VGFPF","VOTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657063925","title":"CG Oncology Q2 Net Loss Widens on Higher R&D Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657063925","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657063925?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:22","pubTimestamp":1786018956,"startTime":"0","endTime":"0","summary":"CG Oncology Q2 net loss widens on higher R&D costsOverviewUS biopharmaceutical firm's Q2 rev rose to $1.2 mln, reflecting early commercialization activityNet loss widened to $79.1 mln, driven by highe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4430OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","CGON","CMPX","BK4139","CHRS","BK4535","AVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657636837","title":"Compass Therapeutics Q2 EPS $(0.13) Misses $(0.11) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657636837","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657636837?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:56","pubTimestamp":1786017390,"startTime":"0","endTime":"0","summary":"Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 7.14 percent increase over losses of $(0.14) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60990703/compass-therapeutics-q2-eps-0-13-misses-0-11-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657337776","title":"Compass Therapeutics Q2 2026 Net Loss Widens 26.63% to $25.2 Million; R&D Expenses Rise 19% to $19.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657337776","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657337776?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:31","pubTimestamp":1786015919,"startTime":"0","endTime":"0","summary":"Compass Therapeutics Q2 2026 net loss widens 26.63% to $25.2 million; R&D expenses rise 19% to $19.6 millionCompass Therapeutics posted a Q2 net loss of USD 25.2 million, widening from USD 19.9 millio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL9QRVgG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657330686","title":"Compass Therapeutics: $180 Mln in Cash and Marketable Securities at End of Q2 2026, Which is Expected to Fund Operations into 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2657330686","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657330686?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:30","pubTimestamp":1786015802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUA68MMQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CMPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657416633","title":"Compass Therapeutics Q2 Income from Operations USD -26.979 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657416633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657416633?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:30","pubTimestamp":1786015802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLX83W2ZT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CMPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657763104","title":"Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657763104","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657763104?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:30","pubTimestamp":1786015800,"startTime":"0","endTime":"0","summary":"The Company expects feedback from the FDA this quarter regarding the COMPANION-002 Phase 2/3 data for tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with biliary tract cancer (BTC), prior t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/06/3340156/0/en/Compass-Therapeutics-Reports-2026-Second-Quarter-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKB","CBXJ","BITX","BRRR","CBTO","BTRN","BAGY","BTC","BTF","BTCZ","BTCW","BTCC","BFJL","XBTY","BFAP","CBXY","ORR","GBTC","BPI","CBOA","HODL","BTCO","CBOJ","MAXI","CBXA","BTCL","BITB","BETH","CBTJ","CBTY","YBTC","BITU","DFII","SBIT","DEFI","CMPX","IBIT","EZBC","CBTA","CBOO","QBF","MNRS","BITO","BTCI","BTFX","CBOY","CBXO","BCCC","FBTC","BITY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652289227","title":"Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the Esmo Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2652289227","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652289227?lang=en_us&edition=fundamental","pubTime":"2026-07-17 22:42","pubTimestamp":1784299361,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA5HG6WQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652289047","title":"Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2652289047","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652289047?lang=en_us&edition=fundamental","pubTime":"2026-07-17 22:42","pubTimestamp":1784299320,"startTime":"0","endTime":"0","summary":"BOSTON, July  17, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/17/3329171/0/en/Compass-Therapeutics-Announces-Tovecimig-Data-Accepted-for-an-Oral-Presentation-at-the-ESMO-Congress-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFII","CBOA","MAXI","BPI","CBOJ","BTC","CBTO","BITI","BITB","BITU","CBOY","YBTC","EZBC","BITY","FBTC","BTFX","MNRS","BETE","BTRN","BITX","BTCO","IBIT","CMPX","CBTJ","BTCZ","HODL","ARKB","CBXO","BCCC","SBIT","GBTC","BAGY","CBXA","BTCC","BITO","BTCW","BTF","BTCL","CBOO","CBXY","BFAP","XBTY","BFJL","BETH","BRRR","CBXJ","DEFI","CBTY","QBF","BTCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648521483","title":"Compass Showcases Promising Tovecimig Data, Eyes Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2648521483","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648521483?lang=en_us&edition=fundamental","pubTime":"2026-07-02 05:30","pubTimestamp":1782941446,"startTime":"0","endTime":"0","summary":"Compass Therapeutics ( ($CMPX) ) has shared an announcement. On July 1, 2026, Compass Therapeutics updated its corporate presentation to highlight ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/compass-showcases-promising-tovecimig-data-eyes-commercialization?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/compass-showcases-promising-tovecimig-data-eyes-commercialization?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648826517","title":"Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH), Compass Therapeutics (CMPX) and 10x Genomics (TXG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648826517","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648826517?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:00","pubTimestamp":1782903657,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zimmer Biomet Holdings (ZBH), Compass Therapeutics...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zimmer-biomet-holdings-zbh-compass-therapeutics-cmpx-and-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zimmer-biomet-holdings-zbh-compass-therapeutics-cmpx-and-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TXG","LU0006061336.USD","LU0130517989.USD","LU0211327993.USD","CMPX","IE00B7SZLL34.SGD","BK4588","LU0211328371.USD","LU1267930573.SGD","LU1267930490.SGD","LU0128525929.USD","BK4139","IE00B19Z3581.USD","LU0029874061.USD","XLV","LU0889566641.SGD","BK4504","BK4121","LU0477156953.USD","BK4137","LU0708994859.HKD","LU0130102774.USD","LU0310799852.SGD","LU1861558580.USD","BK4581","BK4548","LU0128526141.USD","LU0310800379.SGD","LU1201861249.SGD","BK4585","LU0648001328.SGD","BK4082","LU1861559042.SGD","XBI","BK4566","LU0980610538.SGD","IE0002270589.USD","LU0029864427.USD","LABU","LU0792757196.USD","IE00B19Z3B42.SGD","HCSG","LU1267930813.SGD","ZBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645887170","title":"Compass Therapeutics sets Delaware, Massachusetts federal courts as exclusive venue for Securities Act claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2645887170","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645887170?lang=en_us&edition=fundamental","pubTime":"2026-06-23 18:01","pubTimestamp":1782208890,"startTime":"0","endTime":"0","summary":"Compass Therapeutics adopted second amended and restated bylaws effective June 22, 2026.New provisions set exclusive venue in the US District Courts for Delaware or Massachusetts for Securities Act of 1933 claims.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compass Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 23, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL8nv3Fj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642322282","title":"Compass Therapeutics Shareholders Back Directors, Pay, Auditor Oversight","url":"https://stock-news.laohu8.com/highlight/detail?id=2642322282","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642322282?lang=en_us&edition=fundamental","pubTime":"2026-06-12 05:24","pubTimestamp":1781213041,"startTime":"0","endTime":"0","summary":"Compass Therapeutics ( ($CMPX) ) just unveiled an announcement. On June 10, 2026, Compass Therapeutics, Inc. stockholders elected two Class III dir...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/compass-therapeutics-shareholders-back-directors-pay-auditor-oversight?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/compass-therapeutics-shareholders-back-directors-pay-auditor-oversight?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642231614","title":"Compass Therapeutics shareholders elect Schuetz, Lindahl to board","url":"https://stock-news.laohu8.com/highlight/detail?id=2642231614","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642231614?lang=en_us&edition=fundamental","pubTime":"2026-06-12 04:01","pubTimestamp":1781208090,"startTime":"0","endTime":"0","summary":"Compass Therapeutics held its annual shareholder meeting on June 10, 2026.Investors endorsed an annual cadence for future advisory votes on executive pay; the board has set the vote to occur annually.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compass Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL2KDFBW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640952299","title":"Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Compass Therapeutics (CMPX) and Tenax Therapeutics (TENX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640952299","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640952299?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:30","pubTimestamp":1780320613,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Praxis Precision Medicines (PRAX), Compass Therapeut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-compass-therapeutics-cmpx-and-tenax-therapeutics-tenx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-compass-therapeutics-cmpx-and-tenax-therapeutics-tenx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XBI","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE0002141913.USD","BK4581","TENX","LU0029874061.USD","IE00B4R5TH58.HKD","HCSG","CMPX","LU0109394709.USD","BK4137","BK4585","IE00B2B36J28.USD","LU0320765992.SGD","BK4139","LU0128526141.USD","PRAX","IE00BJT1NW94.SGD","XLV","BK4588","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638475660","title":"Compass Therapeutics to Participate in Upcoming June Investor Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2638475660","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638475660?lang=en_us&edition=fundamental","pubTime":"2026-05-28 19:30","pubTimestamp":1779967800,"startTime":"0","endTime":"0","summary":"BOSTON, May  28, 2026  (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/28/3302708/0/en/Compass-Therapeutics-to-Participate-in-Upcoming-June-Investor-Events.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.compasstherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0678},{"period":"1month","weight":0.2353},{"period":"3month","weight":0.0588},{"period":"6month","weight":-0.554},{"period":"1year","weight":-0.2317},{"period":"ytd","weight":-0.5307}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0547},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1215},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1, and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells. It also develops CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. Compass Therapeutics, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.118622},{"month":2,"riseRate":0.4,"avgChangeRate":0.052033},{"month":3,"riseRate":0.2,"avgChangeRate":-0.151702},{"month":4,"riseRate":0.2,"avgChangeRate":-0.191681},{"month":5,"riseRate":0.5,"avgChangeRate":0.179516},{"month":6,"riseRate":0.5,"avgChangeRate":-0.006027},{"month":7,"riseRate":0.5,"avgChangeRate":-0.00672},{"month":8,"riseRate":0.666667,"avgChangeRate":0.102044},{"month":9,"riseRate":0.4,"avgChangeRate":-0.036741},{"month":10,"riseRate":0.4,"avgChangeRate":0.029035},{"month":11,"riseRate":0.6,"avgChangeRate":0.162335},{"month":12,"riseRate":0.2,"avgChangeRate":-0.003054}],"exchange":"NASDAQ","name":"Compass Therapeutics, Inc.","nameEN":"Compass Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Compass Therapeutics, Inc.(CMPX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Compass Therapeutics, Inc.(CMPX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Compass Therapeutics, Inc.,CMPX,Compass Therapeutics, Inc.股票,Compass Therapeutics, Inc.股票老虎,Compass Therapeutics, Inc.股票老虎国际,Compass Therapeutics, Inc.行情,Compass Therapeutics, Inc.股票行情,Compass Therapeutics, Inc.股价,Compass Therapeutics, Inc.股市,Compass Therapeutics, Inc.股票价格,Compass Therapeutics, Inc.股票交易,Compass Therapeutics, Inc.股票购买,Compass Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Compass Therapeutics, Inc.(CMPX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Compass Therapeutics, Inc.(CMPX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}